Engimmune is an immunotherapy company utilising cutting-edge methods for the development of T-cell receptor (TCR)-based immunotherapies including T cell therapies and biologics. By applying our unique protein engineering toolbox we have established and continue to develop proprietary high-throughput technology platforms enabling the discovery of highly potent and safe TCR-based cell therapies and biotherapeutics, thus covering the entire TCR discovery value chain. 

Operating as a platform technology and product development company, our vision is to become a globally leading provider of best-in-class TCR-based therapeutics for the treatment of serious human diseases with high unmet medical need, with a particular focus on oncology.  

Engimmune is based in a brand new science park in Allschwill, Basel in Switzerland

Engimmune Therapeutics

Lars Nieba

This department focuses on scientific research and innovation to advance knowledge and solutions in various domains.

Research and Development

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

This department focuses on conducting and assisting with research projects and studies.

Research Department

This department focuses on bridging laboratory research with clinical applications to enhance patient care and treatment outcomes.

Engimmune Therapeutics

Org chart

Teams

Research and Development

Executive Leadership

Research Department

Translational Medicine

Offices

Engimmune Therapeutics

Org chart

Teams

Research and Development

Executive Leadership

Research Department

Translational Medicine

Offices

Related companies